0001127602-20-001938.txt : 20200117
0001127602-20-001938.hdr.sgml : 20200117
20200117163143
ACCESSION NUMBER: 0001127602-20-001938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200115
FILED AS OF DATE: 20200117
DATE AS OF CHANGE: 20200117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERLO LARRY J
CENTRAL INDEX KEY: 0001194413
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 20533971
MAIL ADDRESS:
STREET 1: ONE CVS DR
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-01-15
0000064803
CVS HEALTH Corp
CVS
0001194413
MERLO LARRY J
ONE CVS DRIVE
WOONSOCKET
RI
02895-
1
1
President and CEO
Common Stock
2020-01-15
4
M
0
314713
54.53
A
703496.9407
D
Common Stock
2020-01-15
4
S
0
266476
74.79
D
437020.9407
D
Common Stock
391070.4564
I
By Trust As Beneficiary
Common Stock (restricted)
81879
D
ESOP Common Stock
7208.3869
I
By ESOP
Stock Unit
665529.4676
D
Stock Option
54.53
2020-01-15
4
M
0
314713
0
D
2014-04-01
2020-04-01
Common Stock
314713
0
D
Phantom Stock Credits
1.00
Common Stock
5158.5846
5158.5846
D
Stock Option
74.29
2015-04-01
2021-04-01
Common Stock
335697
335697
D
Stock Option
102.26
2016-04-01
2022-04-01
Common Stock
273929
273929
D
Stock Option
104.82
2017-04-01
2023-04-01
Common Stock
286787
286787
D
Stock Option
78.05
2018-04-03
2024-04-03
Common Stock
338105
338105
D
Stock Option
62.21
2019-04-01
2025-04-01
Common Stock
394091
394091
D
Stock Option
54.19
2020-04-01
2029-04-01
Common Stock
545419
545419
D
All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.
Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $73.99 and $75.55 per share.
Option became exercisable in four equal annual installments, commencing 4/1/2014.
Each share credit is equivalent to one share; 1-for-1 conversion.
Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option becomes exercisable in four equal annual installments, commencing 4/1/2020.
Larry J. Merlo
2020-01-17